Rezvani, M., & Wiedtke, E. (2016). In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis. Cell stem cell, 18(6), . https://doi.org/10.1016/j.stem.2016.05.005
Chicago Style (17th ed.) CitationRezvani, Milad, and Ellen Wiedtke. "In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis." Cell Stem Cell 18, no. 6 (2016). https://doi.org/10.1016/j.stem.2016.05.005.
MLA (9th ed.) CitationRezvani, Milad, and Ellen Wiedtke. "In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis." Cell Stem Cell, vol. 18, no. 6, 2016, https://doi.org/10.1016/j.stem.2016.05.005.
Warning: These citations may not always be 100% accurate.